Patients who are at a higher risk of their lung cancer returning can be identified by a personalized blood test that is performed after treatment, according to researchers at the University of Cambridge.
Mar 18, 2022
0
72
ESMO, the leading professional organization for medical oncology, announces a new series of resources designed to guide physicians in areas of oncological practice not covered by guidelines, where current evidence is insufficient ...
Feb 28, 2022
0
1
Death rates from ovarian cancer are predicted to fall by 17 percent in the UK and by 7 percent in EU countries in 2022 compared to 2017, according to new research published in the journal Annals of Oncology today.
Jan 26, 2022
0
32
The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
Dec 24, 2021
0
248
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies ...
Nov 2, 2021
0
2
(HealthDay)—A novel deep learning model (DeepGrade [DG]) improves prognostic stratification for Nottingham histologic grade 2 (NHG 2) breast tumors, according to a study published online Sept. 29 in the Annals of Oncology.
Oct 4, 2021
0
0
Researchers at Karolinska Institutet in Sweden have developed an AI-based tool that improves the diagnosis of breast cancer tumors and the ability to predict the risk of recurrence. The greater diagnostic precision can lead ...
Sep 30, 2021
0
7
Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine. Despite medical research suffering setbacks ...
Sep 24, 2021
0
18
A large prospective study of COVID-19 outcomes in people with a history of cancer has found that hospital mortality rates do not appear to have reduced over time, unlike those for people with no history of cancer.
Sep 22, 2021
0
6
The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology, ...
Sep 20, 2021
0
170
